Skip to main content
. 2022 Mar 25;11:17. doi: 10.1186/s40164-022-00268-z

Fig. 1.

Fig. 1

Kaplan–Meier curves for PFS (a) and OS (b) in infused patients, matched-adjusted comparison (primary analysis). CI confidence interval, ESS effective sample size, liso-cel lisocabtagene maraleucel, NR not reached, OS overall survival, PFS progression-free survival